Literature DB >> 3931087

Inhibition of cell proliferation by D-ribose and deoxy-D-ribose.

M Marini, G Zunica, C Franceschi.   

Abstract

D-Ribose and deoxy-D-ribose inhibited DNA, RNA, and protein synthesis in a wide variety of cells (dividing and nondividing, normal and neoplastic, freely floating and substrate adhering, human and murine) at concentrations at which other monosaccharides have little or no effect. Inhibition was irreversible and proportional to the sugar concentration and time of contact. However, the first effects were seen only after 24 hr of incubation and progressed slowly to cell death. Whether the two sugars share the same mechanisms of action is not known. In any case, they deeply disturb metabolic processes in both dividing and nondividing cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931087     DOI: 10.3181/00379727-180-42172

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  5 in total

1.  2-deoxyribose deprives cultured astrocytes of their glutathione.

Authors:  Maike M Schmidt; Helena Greb; Hendrik Koliwer-Brandl; Soerge Kelm; Ralf Dringen
Journal:  Neurochem Res       Date:  2010-08-24       Impact factor: 3.996

2.  Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose.

Authors:  N Zöllner; S Reiter; M Gross; D Pongratz; C D Reimers; K Gerbitz; I Paetzke; T Deufel; G Hübner
Journal:  Klin Wochenschr       Date:  1986-12-15

3.  Metabolism of D-ribose administered continuously to healthy persons and to patients with myoadenylate deaminase deficiency.

Authors:  M Gross; S Reiter; N Zöllner
Journal:  Klin Wochenschr       Date:  1989-12-04

4.  Effects of therapeutic ribose levels on human lymphocyte proliferation in vitro.

Authors:  W Pliml; T von Arnim; C Hammer
Journal:  Clin Investig       Date:  1993-10

5.  The oxidative pentose phosphate pathway in the heart: regulation, physiological significance, and clinical implications.

Authors:  H G Zimmer
Journal:  Basic Res Cardiol       Date:  1992 Jul-Aug       Impact factor: 17.165

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.